Objective: To diagnose ovarian space occupying lesions by trans-vaginal three-dimensional ultrasound parameters, RI, PI, and serum TSGF, then analyze and study their clinical diagnostic values.
Methods: 40 cases of patients with ovarian space occupying lesions, treated in our hospital from May, 2021 to May, 2022, including 20 cases in early stage (the Control Group) and 20 cases in middle stage (the Observation Group), were examined by trans-vaginal three-dimensional ultrasound parameters, RI, PI and serum TSGF, to analyze the diagnostic values.
Results: (1) In Observation Group, 9 cases of patients with ovarian space occupying lesions were mainly diagnosed as malignant ovarian tumors, accounting for 45.00%; In Control Group, 14 cases of patients with ovarian space occupying lesions were mainly diagnosed as benign ovarian tumors, accounting for 70.00%; (2) The index level of serum TSGF (86.79±7.95U/ml VS 65.94±9.46U/ml) in ovarian space occupying lesions in the Observation Group was higher while PI (1.21±0.16mmol/L VS 2.34±0.06mmol/L) and RI (0.68±0.03mmol/L VS 0.76± 0.06 mmol/L) were lower (p<0.05) compared with the Control Group; (3) The index levels of CA125 (346.83±153.73RU/L VS 39.94±16.54RU/L) and CEA (36.25±17.08μg/L VS 17.46±4.72μg/L) in the Observation Group were higher than those in the Control Group(p<0.05); (4) The ADC means of the cystic portion (2752.39 ± 87.49vs3719.68 ± 84.76) and the solid portion (884.47 ± 71.98vs989.47 ± 76.79) in the Observation Group were lower than those in the Control Group (p<0.05).
Conclusion: The diagnosis of ovarian space occupying lesions by trans-vaginal three-dimensional ultrasound parameters RI, PI and serum TSGF, could significantly increase the clinical value and accuracy for the diagnosis of ovarian space occupying lesions. Early diagnosis and treatment were of great significance, and shall be recommended and available in clinical practice.